Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
03
2022
revised:
13
05
2022
accepted:
25
05
2022
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
10
8
2022
Statut:
epublish
Résumé
Cancer-associated thrombosis (CAT) is the second main cause of cancer death with high related mortality and morbidity, leading to anticancer agent delays and interruptions. The recommended therapy, low-molecular-weight heparin (LMWH), however, is burdensome for patients and costly for society, as treatment should last until cancer is no longer active, even indefinitely. Tinzaparin is a manageable, efficient, safe, and cost-effective option. Compared to the other LMWHs, advantages are single-daily dose and safety in the elderly and those with renal impairment (RI). The purpose of this review is to critically discuss recent data on its efficacy and safety in CAT.
Identifiants
pubmed: 35936060
doi: 10.1155/2022/2582923
pmc: PMC9325617
doi:
Substances chimiques
Heparin, Low-Molecular-Weight
0
Tinzaparin
7UQ7X4Y489
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2582923Informations de copyright
Copyright © 2022 Agnese Maria Fioretti et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Thromb Res. 2015 Jan;135(1):78-83
pubmed: 25466839
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620979592
pubmed: 33464938
Minerva Med. 2019 Jun;110(3):251-258
pubmed: 30990000
J Cell Physiol. 2019 Apr;234(4):4191-4199
pubmed: 30362518
Cancers (Basel). 2020 Aug 12;12(8):
pubmed: 32806574
Am J Cardiovasc Drugs. 2020 Jun;20(3):223-228
pubmed: 31721053
Blood Coagul Fibrinolysis. 2010 Dec;21(8):744-9
pubmed: 20885298
Am J Med. 2006 Dec;119(12):1062-72
pubmed: 17145251
N Engl J Med. 2003 Jul 10;349(2):146-53
pubmed: 12853587
J Thromb Haemost. 2011 Oct;9(10):1966-72
pubmed: 21819539
Ann Intern Med. 2002 Dec 17;137(12):955-60
pubmed: 12484710
J Oncol Pharm Pract. 2019 Jan;25(1):68-75
pubmed: 28857713
Swiss Med Wkly. 2009 Aug 8;139(31-32):438-52
pubmed: 19685350
Clin Appl Thromb Hemost. 2013 Sep;19(5):476-81
pubmed: 23520150
J Clin Oncol. 2017 Apr 1;35(10):1078-1085
pubmed: 28029329
Thromb Res. 2016 Aug;144:85-92
pubmed: 27318244
JACC CardioOncol. 2021 Apr 20;3(2):173-190
pubmed: 34396323
Hamostaseologie. 2012;32(2):115-25
pubmed: 21971578
Int J Mol Sci. 2021 Jun 30;22(13):
pubmed: 34208987
J Neurooncol. 2009 Oct;95(1):129-134
pubmed: 19415455
Thromb Res. 2010 Jun;125(6):490-3
pubmed: 20097409
J Clin Oncol. 2014 Nov 10;32(32):3607-12
pubmed: 25267738
Turk J Urol. 2020 May 08;:
pubmed: 32412407
J Thromb Haemost. 2018 Jun;16(6):1069-1077
pubmed: 29573330
Thromb Res. 2017 Sep;157:90-96
pubmed: 28719850
J Clin Oncol. 2020 Feb 10;38(5):496-520
pubmed: 31381464
J Cell Physiol. 2018 Oct;233(10):6523-6529
pubmed: 29741755
Oncologist. 2016 Jul;21(7):861-7
pubmed: 27125754
JAMA. 2015 Aug 18;314(7):677-686
pubmed: 26284719
Thromb Res. 2015 Feb;135 Suppl 1:S8-S11
pubmed: 25903541
Thromb Res. 2012 Dec;130(6):853-8
pubmed: 22939430
Eur J Vasc Endovasc Surg. 2005 Jun;29(6):638-50
pubmed: 15878544
Thromb Haemost. 2022 Jan;122(1):151-157
pubmed: 33878800
Oncologist. 2021 Jan;26(1):e24-e40
pubmed: 33275332
Clin Appl Thromb Hemost. 2018 Mar;24(2):226-234
pubmed: 28288527
APMIS. 2006 Feb;114(2):79-102
pubmed: 16519745
Eur J Vasc Endovasc Surg. 2009 Mar;37(3):349-56
pubmed: 19121589
Blood Coagul Fibrinolysis. 2011 Dec;22(8):760-2
pubmed: 22198365
Thromb Res. 2011 Jul;128(1):27-34
pubmed: 21477846
J Thromb Haemost. 2016 Mar;14(3):421-6
pubmed: 26711899
Thromb Res. 2021 Sep 7;207:25-32
pubmed: 34530386
Am J Med. 2009 Aug;122(8):762-769.e3
pubmed: 19635277
Drugs. 2004;64(13):1479-502
pubmed: 15212562
Am J Med. 2007 Jan;120(1):72-82
pubmed: 17208082
Exp Hematol Oncol. 2013 Aug 08;2:21
pubmed: 23927414
J Cancer. 2017 Aug 25;8(15):2899-2906
pubmed: 28928880
Thromb Haemost. 2018 May;118(5):914-921
pubmed: 29618162
Curr Opin Pulm Med. 2007 Sep;13(5):409-13
pubmed: 17940486
BMC Cancer. 2013 Jun 13;13:284
pubmed: 23764005
Cancers (Basel). 2021 Jun 09;13(12):
pubmed: 34207591
Blood. 2002 Nov 15;100(10):3484-8
pubmed: 12393647
Anticancer Res. 2020 Jan;40(1):305-313
pubmed: 31892581
Semin Thromb Hemost. 2004 Feb;30 Suppl 1:3-9
pubmed: 15085461
Clin Appl Thromb Hemost. 2018 Jul;24(5):697-707
pubmed: 29088922
Blood. 2013 Sep 5;122(10):1712-23
pubmed: 23908465
Support Care Cancer. 2012 Dec;20(12):3033-42
pubmed: 22960941
J Clin Oncol. 2005 Apr 1;23(10):2123-9
pubmed: 15699480